Cancer is rapidly becoming a public health crisis in low-income and middle-income countries. In sub-Saharan Africa, patients often present with advanced disease. Little health-care infrastructure exists, and few personnel are available for the care of patients.
70% of the 24 million people predicted to have cancer by 2050 will live in low- and middle-income countries (LMIC). As a result, cancer care is becoming a priority for healthcare systems in West Africa.
Breast cancer incidence may be increasing in low‐ and middle‐income countries (LMIC). This study estimates the prevalence of breast masses in Rwanda (RW) and Sierra Leone (SL) and identifies barriers to care for women with breast masses only.
This study aimed to describe the characteristics of patients diagnosed with hepatocellular carcinoma (HCC) at the Komfo Anokye Teaching Hospital (KATH) in Ghana and to determine their treatment options per the Barcelona Clinic Liver Cancer (BCLC) algorithm.
Both infectious and noninfectious related malignancies are a growing problem in low- and middle-income countries (LMIC). It is difficult to extrapolate data and guidelines regarding cancer care from high-income countries (HIC) to cancer patients in LMIC. Due to the rise in noncommunicable cancer rates,
Cancer care is quickly becoming a key component of global public health efforts. At the same time, the cancer incidence rate in low- and middle-income countries (LMIC) continues to increase dramatically. Only 15 % of cancers reported in 1970 were in LMIC, but 70 % is the proportion predicted by 2030
Surgery is essential for global cancer care in all resource settings. Of the 15·2 million new cases of cancer in 2015, over 80% of cases will need surgery, some several times. By 2030, we estimate that annually 45 million surgical procedures will be needed worldwide.
Noncommunicable diseases are now recognized by the United Nations and WHO as a major public health crisis. Cancer is a main part of this problem, and health care systems are facing a great challenge to improve cancer care, control costs, and increase systems efficiency.
Hepatocellular carcinoma (HCC) is highly endemic in Africa (1). There is a general anecdotal consensus that persons with HCC induced by viral hepatitis or other causes in Africa present at younger ages than in other regions of the World.
There is an increasing effort in the global public health community to strengthen research capacity in low- and middle-income countries, but there is no consensus on how best to approach such endeavors. Successful consortia that perform research on HIV/AIDS and other infectious diseases exist, but few papers have been published detailing the challenges faced and lessons learned in setting up and running a successful research consortium.